High output CHF Flashcards

1
Q

Regulators of IV volume

A
  • Complex interaction of regulators of IV volume in any low cardiac output states
    o Heart
    o Kidneys
    o SNS
    o RAAS
    o Cellular/inflammatory modulators
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Homeostasis of arterial circulation: 2 main determinants

A

CO and PVR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is arterial underfilling and physiologic response

A

o ↓BP from ↓CO +/- vasodilation → ARTERIAL UNDERFILLING
o Neurohormonal response: retain Na+ and H2O
 Maladaptive with heart disease → volume overload and failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the most common cause of ventricular underfilling and c/s

A

Cardiac tamponade
 Intracardiac mass lesions → obstruction of blood flow
o C/s: episodic weakness (↓ CO and forward flow)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What defines high output CHF

A
  • CO is already elevated before CHF occurs
  • Chronic ↑ in venous return
    o ↑CO from ↑ peripheral demand
    o ↓ peripheral resistance → ↑ increased tissue metabolism and oxygenation
    o Potential for circulatory overload → ↑ LV end diastolic P
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Etiology of high output CHF

A

o ↑ tissue metabolism/O2 demand
 Obesity
 Thyrotoxicosis
 Fever
 Pregnancy

o Hyperkinetic states
 Anemia
 Large or multiple small AV fistulas

o Excess H2O/salt → kidney pathology, fluid administration, steroids
o Liver cirrhosis
o Beriberi syndrome
o Septic shock via gram –

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Thyrotoxicosis: pathophys of high output

A

→ most common cause in vetmed (cats)
* May cause reversible cardiomyopathy
* ↑ metabolic rate and tissue O2 consumption + ↓ peripheral resisatance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Thyrotoxicosis: factors influcencing dev of high output CHF

A

o Chronicity and rate of development of thyrotoxicosis (most important factors)
o Underlying cardiac disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Anemia: pathophys of high output. On what depends its development?

A
  • Cardiovascular response depend on rate of development + magnitude
    o Slowly developing anemia: ↑CO from tachycardia with stable SV
    o Chronic severe anemia: ↑ CO from ↑SV
     ↓ blood viscosity
     ↓ BP → ↓ afterload
  • Tissue hypoxia and vasodilator metabolites
     ↑ preload
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Large/multiple AV fistula: pathophys high output

A
  • Excessive venous return + normal systolic function
    o ↑CO with normal RAP
    o Little cardiac reserve: if acute ↑ demand (ie. exercise) → high output failure
     Heart already at max capacity with pumping extra blood volume
  • Mild signs of peripheral venous congestion
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Cause of Beriberi syndrome

A

 Thiamine or vitamin B1 deficiency → ↓ systolic function

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Beriberi pathophys

A

 ↑ venous return from ↓ vascular resistance + ↓ systolic function
* CO curve shifted L and downward
* ↓CO → ↓ blood flow to kidneys → RAAS activation → H2O/Na+ retention
 Slight ↑CO at ↑ venous pressures → high output failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Clinical manif high output CHF

A

o Hyperkinetic femoral pulses
o Soft systolic cardiac murmur
o Gallop rhythm
o Eccentric cardiac hypertrophy/generalized cardiomegaly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Thyroid hormones

A
  • Thyroid gland → secrete 2 biologically active hormones
    o Triiodothyronine T3 → major mediator of thyroid actions
    o Thyroxine T4
     Less active
     Circulating reservoir for conversion into T3
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Action site of thyroid hormones

A

intranuclear
o Bind to chromatin-bound nonhistone nucleoprotein
o Alterations in protein synthesis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Biological response to T4 in tissues

A

o Changes in myocardial contractility
o Stimulation of myocardial hypertrophy
o ↑ responsiveness to ∑ stimulation
o ↑ myocardial O2 consumption: ↑ protein synthesis + glucose/Ca2+ transport

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

How does T4 affect myocardial contractility

A

 ↑ activity in Na/K/ATPase pump → sarcolemmal pump
 ↑ synthesis in ventricular myosin
 Alteration of myosin isoenzyme → predominance of fast ATPase activity
 Changes in Ca2+ handling

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Describe ventricular myosin isoenzymes types and regulation w/ T4

A

 Alteration of myosin isoenzyme → predominance of fast ATPase activity
* Ventricular myosin isoenzymes:
o Expression dictated by
 Stage of development
 Thyroid hormone status
o 3 types, each have α and β chains
 V1: α - α homodimer → highest ATPase activity
 V2: α - β heterodimer
 V3: β - β homodimer → lowest ATPase activity
* ATPase activity correlates with velocity of shortening
o Regulation of isoenzymes: control of gene coding for α and β chains

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

How does ca2+ handling changes w/ hyper T4

A
  • ↑# of L-type Ca2+ channels in sarcolemma
  • ↑SR efficiency for Ca2+ uptake/release
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Clinical recognizable effects of T4

A

o ↑HR
o ↑ inotropic state
o ↑ ventricular size/mass

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

HypoT4 and effect on heart

A
  • Thyroid hormone deficiency → ↓ myocardial contractility
    o Reversible
    o Controversial if can cause alone DCM and CHF
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Molecular changes in heart w/ hypoT4

A

o Adrenergic R system: ↓ responsiveness to catecholamines
 ↓# of β-R by 30-40% in rats
 ↓ physiologic responsiveness: ↓max response
 No change in R affinity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Cause of K9 hypoT4

A

Commonly recognized endocrinopathy in dogs
* Cause: idiopathic atrophy or IM thyroiditis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

K9 hypoT4: c/s

A

usually middle age, variable
o Lethargy, mental dullness
o Exercise intolerance
o Dermatologic lesions
o Reproductive system
o Neuromuscular system
o Cardiovascular signs: bradycardia, weak apex beat, arrhythmias

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
K9 hypoT4: ECG changes
severe hypoT4, reverse with supplementation  Sinus bradycardia  Conduction disturbance → PR prolongation  ↓QRS voltage and ↑ duration  MEA deviation  Flattened, inverted T waves
26
K9 hypoT4: echo changes
 Thinning of LVFW and IVS  ↓FS%  ↓LVFW excursion  Alteration of systolic and diastolic function parameters
27
Direct effect of hyperT4 on heart/vasculature
o Tachycardia o Hypertrophy o ↑ contractility o Arrhythmias o ↓ reserve capacity if ↑ cardiac work necessary
28
effect of hyperT4 on myocardial prot synthesis
o ↑ protein synthesis: mitochondrial, ion pump, contractile proteins o Alteration of myosin subtype: slow V3 to fast V1 o ↓ efficiency of energy conversion from chemical (ATP) → mechanical force
29
Myocardial hypertrophy results from
 Chronic volume overload  ↑ ∑ tone  Systemic hypertension → ↑ afterload  Stimulation of myocardial protein synthesis
30
Response of adrenergic system to hyperT4
o ↑ ∑ activity o ↑ responsiveness of cardiac tissue to ∑ stimulus o Upregulation of β-R
31
Electrophysiologic changes hyperT4
o ↑ rate of spontaneous depolarization by SA node cells o Shortened action potential duration
32
Most common endocrinopathy cats
HyperT4
33
Pathophys hyperT4 and heart
* High output state: o ↑ metabolic rate and tissue O2 consumption o ↓ peripheral resistance * Compensatory cardiac remodelling o Changes in myocardial protein synthesis/degradation → hypertrophy * Direct action of thyroid hormones on heart muscle + interaction with ∑ nervous system o Stimulate cardiac hypertrophy o ↑plasma volume + systemic BP o ↑CO, filling pressures, HR, contractility
34
Feline HyperT4: signalment/hx
o Middle aged – old cats o Uncommon <6y/o o C/s: weight loss, polyphagia, V+, PUPD, ↑ activity, unkept hair coat  5% of cats can have weakness, profound depression, anorexia → apathetic syndrome in Hu
35
Feline HyperT4: PE
thyroid nodules o Soft – moderate systolic murmurs +/- gallop o Tachycardia o Hyperkinetic pulse
36
Feline HyperT4: BW
o CBC: leucocytosis, eosinopenia, ↑PCV o Chem: ↑ALT (83%), ALP (58%), AST (43%)
37
Feline HyperT4: ECG
Resolve after euthyroid state o Sinus tachycardia (38%) o ↑ R wave amplitude (8%) o Atrial (3%), ventricular (4%) arrhythmias o IV conduction disturbances: RBBB
38
Feline HyperT4: echo
mimic HCM, resolve after euthyroid state o LVH o LA/LVE o Hypercontractile state: ↑FS% and Vcf o ↑Ao root dimension o DCM phenotype reported → ↓ systolic function, ventricular dilation
39
Feline HyperT4: thyroid imaging
* Radionuclide thyroid imaging o Delineates functioning thyroid tissue  Extent of thyroid gland involvement  Metastatic/ectopic thyroid tissue  1 or both thyroid involved  Detect functional thyroid adenocarcinoma metastasis o Pertechnetate: shorter ½ life, rapid uptake
40
Feline HyperT4: tx
* Antithyroid drug * Surgical thyroidectomy * Radioactive iodine I-131
41
Feline HyperT4: thyroid fct testing
 ↑ baseline T3 and T4  Occult hyperthyroidism: normal T4 and T3 * Suppression of high T4/T3 because of concurrent nonthyroidal illness * Fluctuation in and out of normal range  T3 suppression test → thyrotropin releasing hormone (TRH) stim test  Basal free T4 (unbounded)
42
Effects and options for anti thyroid drugs
o ↓circulating [T3/T4] by inhibiting thyroid hormone synthesis w/o destroying thyroid tissue Propylthiouracil Methimazole Carbimazole Ca2+/Na+ ipodate
43
Side effects Propylthiouracil
high incidence of side effects: anorexia, V+, lethargy, IMHA, thrombocytopenia
44
Side effects methimazole
better tolerated, safer * Side effects: usually anorexia, lethargy, V+ transient o V+/D+/anorexia o Facial pruritus o Hepatotoxicity o Hematologic abnormalities: thrombocytopenia, IMHA, agranulocytosis
45
Carbimazole features
carbethoxy derivative of methimazole * Alternative if methimazole not available, TID * Similar side effects, ↓ incidence
46
Why use B blockers for hyperT4
* Used to block some cardiovascular effects of thyroid hormone * Not for routine tx
47
Sx for hyperT4
o Medical tx prior → euthyroid state for 1-2 wks  ↓ anesthetic risks (arrhythmias, CHF) o Removal of abnormal thyroid tissue + preserve parathyroid gland  Intracapsular technique: thyroid parenchyma dissected from capsule * Preserves external parathyroid gland * Risk of small remanants remaining attached to capsule  Extracapsular technique: thyroid gland + capsule removed * Risk of hypoparathyroidism * Modified technique: capsule adjacent to parathyroid gland incised and left attached
48
Post op complications thyroidectomy
 HypoCa2+/hypoparathyroidism 1-3 days post op  Hypothyroidism 2-3mo post op  Horner’s syndrome  Renal failure (↓GFR)  Laryngeal paralysis  Recurrent hyperthyroidism if ectopic tissue, incomplete resection
49
Radioactive I131
o Selectively destroy hyperplastic/neoplastic thyroid tissue o Long hospitalization, iodine regulations
50
What can influence tx modality
Coexistent cardiovascular disease, renal failure
51
Pheochromocytoma: etiology
* Endocrine tumor of adrenal medulla o Chromaffin cells → pheochromocytes o Most often solitary o Functional neoplasms → ability to secrete NE/epi/dopamine  Epinephrine = 85% of adrenal gland secretion in normal gland in dogs/Hu  Norepi = primary secretory product in cats * Distinguished from normal gland by lack of innervation o Hormone secretion NOT mediated by neural impulse o Exocytosis of storage granules
52
Pheochromocytoma: more common in
* Dogs >>> cats
53
Pheochromocytoma: pathophys
* Excess in catecholamines: o Secreted constantly, episodically or both  Hypertension  Overload cardiomyopathy  Arrhythmias  Ischemic myocarditis o NE/epi → α1, β1, β2 stimulation → dominant effect depend on R density  α1 → venous/arteriolar vasoconstriction  β1 → positive chronotropic, dromotropic, inotropic  β2 → venous/arteriolar vasodilation * α1 and β1 respond to Epi + NE * β2 respond to epi
54
Pheochromocytoma: myocardial injury
from coronary vasoconstriction, ischemia, ↑SR permeability, Ca2+ overload * Multifocal cardiomyocyte necrosis/degeneration * Contraction band * Interstitial fibrosis * Myocardial hemorrhage * Lymphohistiocytic myocarditis
55
Pheochromocytoma: resp distress
similar to ARDS  Pulmonary edema  Capillary micro-hemorrhage  Capillary shrinkage
56
Pheochromocytoma: malignancy
* Local vascular invasion: o Renal, adrenal, hepatic vessels o Metastasis
57
Pheochromocytoma: c/s
mainly from systemic hypertension o Anorexia, hyperT o Panting, cough, dyspnea, cyanosis o Weakness, trembling o Mydriasis, hypertensive retinopathy o Proteinuria, PUPD o Neurologic signs o Epistaxis o Abdominal distension o Collapse/death
58
Pheochromocytoma: PE
o Hypertension (50% of dogs) o Auscultation: arrhythmias, systolic murmur, pulmonary crackles, tachycardia
59
Pheochromocytoma: BW
o Neutrophilic leucocytosis o ↑liver enzymes o Hypercholesterolemia → catecholamine induced lipolysis → conversion of free fatty acid → cholesterol
60
Pheochromocytoma: dx testing
o Plasma or urinary catecholamine  Episodic secretion o Metanephrines: metabolites  Production of metanephrine in tumor cells is autonomous and continuous * Accurately reflect tumor mass o Urinary ratios to creatinine can be calculated
61
Pheochromocytoma: ECG
o Short PR o Short QRS o LVE o Atrial/ventricular arrhythmias o T wave inversion, ST segment deviation
62
Pheochromocytoma: Abd Xrays
tumor visualized in 33% of cases
63
Pheochromocytoma: echo
o LVH o SAM o Normal function o Myocarditis o Reversible CM and CHF
64
Pheochromocytoma: gold std dx
* AUS or CT
65
Pheochromocytoma: tx
* α adrenergic blocking agent → control hypertension o Phenoxybenzamine o Phentolamine o Medical tx 3-4wk prior to sx ↑ success rate * β adrenergic blocking agent → control arrhythmias o Propanolol o Atenolol * Surgical removal = only definitive cure